Global Oral Anti-diabetes Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 110
Published Date: 10 Jan 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels of blood glucose, which can cause severe damage to blood vessels, heart, kidneys, nerves, and eyes. Diabetes is also called hyperglycemia or raised blood sugar. Insulin is a hormone that regulates the blood sugar level in body. Continuous increase in blood sugar leads to diabetes. Uncontrollable diabetes can damage the nervous system and other body systems. Diabetes is of two types: type 1 and type 2. Type 1 diabetes, also known as juvenile diabetes or insulin-dependent diabetes, arises when the immune system misguidedly attacks and kills the beta cells of the pancreas. In type 1 diabetes, little or no insulin is released into the body, owing to this sugar builds up in the blood instead of being used as energy. Type 1 diabetes is rare, and only 10% of people with diabetes have type 1 diabetes. It commonly occurs in childhood or adolescence. Type 2 diabetes arises when the body cannot appropriately use the insulin that is released or does not make enough insulin. As a consequence, sugar builds up in the blood instead of being used as energy. About 90% of people with diabetes have type 2 diabetes.
According to our (Global Info Research) latest study, the global Oral Anti-diabetes Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Oral Anti-diabetes Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oral Anti-diabetes Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oral Anti-diabetes Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oral Anti-diabetes Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oral Anti-diabetes Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Anti-diabetes Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Anti-diabetes Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Eli Lilly, AstraZeneca plc, Astellas Pharma Inc and Johnson & Johnson (Janssen Pharmaceuticals), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oral Anti-diabetes Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
by Type
Liquid
Capsule
Tablet
by Drug Class
Sulfonylureas
Meglitinides
Biguanides
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Sanofi
Eli Lilly
AstraZeneca plc
Astellas Pharma Inc
Johnson & Johnson (Janssen Pharmaceuticals)
Boehringer Ingelheim
Merck
Takeda
Bristol Myers Squibb
Novartis
Pfizer
Abbott
Biocon
Sunpharma
Novo Nordisk
Piramal Healthcare
Bayer Healthcare
Dr. Reddy’s Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Anti-diabetes Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Anti-diabetes Drugs, with revenue, gross margin and global market share of Oral Anti-diabetes Drugs from 2018 to 2023.
Chapter 3, the Oral Anti-diabetes Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oral Anti-diabetes Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Anti-diabetes Drugs.
Chapter 13, to describe Oral Anti-diabetes Drugs research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oral Anti-diabetes Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oral Anti-diabetes Drugs by Type
1.3.1 Overview: Global Oral Anti-diabetes Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oral Anti-diabetes Drugs Consumption Value Market Share by Type in 2022
1.3.3 Liquid
1.3.4 Capsule
1.3.5 Tablet
1.4 Global Oral Anti-diabetes Drugs Market by Application
1.4.1 Overview: Global Oral Anti-diabetes Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Oral Anti-diabetes Drugs Market Size & Forecast
1.6 Global Oral Anti-diabetes Drugs Market Size and Forecast by Region
1.6.1 Global Oral Anti-diabetes Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oral Anti-diabetes Drugs Market Size by Region, (2018-2029)
1.6.3 North America Oral Anti-diabetes Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Oral Anti-diabetes Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oral Anti-diabetes Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Oral Anti-diabetes Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oral Anti-diabetes Drugs Market Size and Prospect (2018-2029)
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Oral Anti-diabetes Drugs Product and Solutions
2.1.4 Sanofi Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Oral Anti-diabetes Drugs Product and Solutions
2.2.4 Eli Lilly Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 AstraZeneca plc
2.3.1 AstraZeneca plc Details
2.3.2 AstraZeneca plc Major Business
2.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Product and Solutions
2.3.4 AstraZeneca plc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca plc Recent Developments and Future Plans
2.4 Astellas Pharma Inc
2.4.1 Astellas Pharma Inc Details
2.4.2 Astellas Pharma Inc Major Business
2.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Product and Solutions
2.4.4 Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Astellas Pharma Inc Recent Developments and Future Plans
2.5 Johnson & Johnson (Janssen Pharmaceuticals)
2.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Details
2.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Major Business
2.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product and Solutions
2.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments and Future Plans
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Product and Solutions
2.6.4 Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boehringer Ingelheim Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Oral Anti-diabetes Drugs Product and Solutions
2.7.4 Merck Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments and Future Plans
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Oral Anti-diabetes Drugs Product and Solutions
2.8.4 Takeda Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Product and Solutions
2.9.4 Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Oral Anti-diabetes Drugs Product and Solutions
2.10.4 Novartis Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Oral Anti-diabetes Drugs Product and Solutions
2.11.4 Pfizer Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Recent Developments and Future Plans
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Oral Anti-diabetes Drugs Product and Solutions
2.12.4 Abbott Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Abbott Recent Developments and Future Plans
2.13 Biocon
2.13.1 Biocon Details
2.13.2 Biocon Major Business
2.13.3 Biocon Oral Anti-diabetes Drugs Product and Solutions
2.13.4 Biocon Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biocon Recent Developments and Future Plans
2.14 Sunpharma
2.14.1 Sunpharma Details
2.14.2 Sunpharma Major Business
2.14.3 Sunpharma Oral Anti-diabetes Drugs Product and Solutions
2.14.4 Sunpharma Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sunpharma Recent Developments and Future Plans
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business
2.15.3 Novo Nordisk Oral Anti-diabetes Drugs Product and Solutions
2.15.4 Novo Nordisk Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Novo Nordisk Recent Developments and Future Plans
2.16 Piramal Healthcare
2.16.1 Piramal Healthcare Details
2.16.2 Piramal Healthcare Major Business
2.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Product and Solutions
2.16.4 Piramal Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Piramal Healthcare Recent Developments and Future Plans
2.17 Bayer Healthcare
2.17.1 Bayer Healthcare Details
2.17.2 Bayer Healthcare Major Business
2.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Product and Solutions
2.17.4 Bayer Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Bayer Healthcare Recent Developments and Future Plans
2.18 Dr. Reddy’s Laboratories Ltd
2.18.1 Dr. Reddy’s Laboratories Ltd Details
2.18.2 Dr. Reddy’s Laboratories Ltd Major Business
2.18.3 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product and Solutions
2.18.4 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.19 Glenmark Pharmaceuticals Ltd
2.19.1 Glenmark Pharmaceuticals Ltd Details
2.19.2 Glenmark Pharmaceuticals Ltd Major Business
2.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product and Solutions
2.19.4 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Glenmark Pharmaceuticals Ltd Recent Developments and Future Plans
3.1 Global Oral Anti-diabetes Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oral Anti-diabetes Drugs by Company Revenue
3.2.2 Top 3 Oral Anti-diabetes Drugs Players Market Share in 2022
3.2.3 Top 6 Oral Anti-diabetes Drugs Players Market Share in 2022
3.3 Oral Anti-diabetes Drugs Market: Overall Company Footprint Analysis
3.3.1 Oral Anti-diabetes Drugs Market: Region Footprint
3.3.2 Oral Anti-diabetes Drugs Market: Company Product Type Footprint
3.3.3 Oral Anti-diabetes Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Oral Anti-diabetes Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oral Anti-diabetes Drugs Market Forecast by Type (2024-2029)
5.1 Global Oral Anti-diabetes Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Oral Anti-diabetes Drugs Market Forecast by Application (2024-2029)
6.1 North America Oral Anti-diabetes Drugs Consumption Value by Type (2018-2029)
6.2 North America Oral Anti-diabetes Drugs Consumption Value by Application (2018-2029)
6.3 North America Oral Anti-diabetes Drugs Market Size by Country
6.3.1 North America Oral Anti-diabetes Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
7.1 Europe Oral Anti-diabetes Drugs Consumption Value by Type (2018-2029)
7.2 Europe Oral Anti-diabetes Drugs Consumption Value by Application (2018-2029)
7.3 Europe Oral Anti-diabetes Drugs Market Size by Country
7.3.1 Europe Oral Anti-diabetes Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
7.3.3 France Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
8.1 Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region
8.3.1 Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Region (2018-2029)
8.3.2 China Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
8.3.5 India Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
9.1 South America Oral Anti-diabetes Drugs Consumption Value by Type (2018-2029)
9.2 South America Oral Anti-diabetes Drugs Consumption Value by Application (2018-2029)
9.3 South America Oral Anti-diabetes Drugs Market Size by Country
9.3.1 South America Oral Anti-diabetes Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
10.1 Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country
10.3.1 Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Oral Anti-diabetes Drugs Market Size and Forecast (2018-2029)
11.1 Oral Anti-diabetes Drugs Market Drivers
11.2 Oral Anti-diabetes Drugs Market Restraints
11.3 Oral Anti-diabetes Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 Oral Anti-diabetes Drugs Industry Chain
12.2 Oral Anti-diabetes Drugs Upstream Analysis
12.3 Oral Anti-diabetes Drugs Midstream Analysis
12.4 Oral Anti-diabetes Drugs Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oral Anti-diabetes Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral Anti-diabetes Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oral Anti-diabetes Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oral Anti-diabetes Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Oral Anti-diabetes Drugs Product and Solutions
Table 8. Sanofi Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Eli Lilly Company Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly Oral Anti-diabetes Drugs Product and Solutions
Table 13. Eli Lilly Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eli Lilly Recent Developments and Future Plans
Table 15. AstraZeneca plc Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca plc Major Business
Table 17. AstraZeneca plc Oral Anti-diabetes Drugs Product and Solutions
Table 18. AstraZeneca plc Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AstraZeneca plc Recent Developments and Future Plans
Table 20. Astellas Pharma Inc Company Information, Head Office, and Major Competitors
Table 21. Astellas Pharma Inc Major Business
Table 22. Astellas Pharma Inc Oral Anti-diabetes Drugs Product and Solutions
Table 23. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Astellas Pharma Inc Recent Developments and Future Plans
Table 25. Johnson & Johnson (Janssen Pharmaceuticals) Company Information, Head Office, and Major Competitors
Table 26. Johnson & Johnson (Janssen Pharmaceuticals) Major Business
Table 27. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product and Solutions
Table 28. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments and Future Plans
Table 30. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 31. Boehringer Ingelheim Major Business
Table 32. Boehringer Ingelheim Oral Anti-diabetes Drugs Product and Solutions
Table 33. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Boehringer Ingelheim Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck Oral Anti-diabetes Drugs Product and Solutions
Table 38. Merck Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Merck Recent Developments and Future Plans
Table 40. Takeda Company Information, Head Office, and Major Competitors
Table 41. Takeda Major Business
Table 42. Takeda Oral Anti-diabetes Drugs Product and Solutions
Table 43. Takeda Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Takeda Recent Developments and Future Plans
Table 45. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 46. Bristol Myers Squibb Major Business
Table 47. Bristol Myers Squibb Oral Anti-diabetes Drugs Product and Solutions
Table 48. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol Myers Squibb Recent Developments and Future Plans
Table 50. Novartis Company Information, Head Office, and Major Competitors
Table 51. Novartis Major Business
Table 52. Novartis Oral Anti-diabetes Drugs Product and Solutions
Table 53. Novartis Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Novartis Recent Developments and Future Plans
Table 55. Pfizer Company Information, Head Office, and Major Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Oral Anti-diabetes Drugs Product and Solutions
Table 58. Pfizer Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer Recent Developments and Future Plans
Table 60. Abbott Company Information, Head Office, and Major Competitors
Table 61. Abbott Major Business
Table 62. Abbott Oral Anti-diabetes Drugs Product and Solutions
Table 63. Abbott Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Abbott Recent Developments and Future Plans
Table 65. Biocon Company Information, Head Office, and Major Competitors
Table 66. Biocon Major Business
Table 67. Biocon Oral Anti-diabetes Drugs Product and Solutions
Table 68. Biocon Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Biocon Recent Developments and Future Plans
Table 70. Sunpharma Company Information, Head Office, and Major Competitors
Table 71. Sunpharma Major Business
Table 72. Sunpharma Oral Anti-diabetes Drugs Product and Solutions
Table 73. Sunpharma Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Sunpharma Recent Developments and Future Plans
Table 75. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 76. Novo Nordisk Major Business
Table 77. Novo Nordisk Oral Anti-diabetes Drugs Product and Solutions
Table 78. Novo Nordisk Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Novo Nordisk Recent Developments and Future Plans
Table 80. Piramal Healthcare Company Information, Head Office, and Major Competitors
Table 81. Piramal Healthcare Major Business
Table 82. Piramal Healthcare Oral Anti-diabetes Drugs Product and Solutions
Table 83. Piramal Healthcare Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Piramal Healthcare Recent Developments and Future Plans
Table 85. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 86. Bayer Healthcare Major Business
Table 87. Bayer Healthcare Oral Anti-diabetes Drugs Product and Solutions
Table 88. Bayer Healthcare Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bayer Healthcare Recent Developments and Future Plans
Table 90. Dr. Reddy’s Laboratories Ltd Company Information, Head Office, and Major Competitors
Table 91. Dr. Reddy’s Laboratories Ltd Major Business
Table 92. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product and Solutions
Table 93. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Table 95. Glenmark Pharmaceuticals Ltd Company Information, Head Office, and Major Competitors
Table 96. Glenmark Pharmaceuticals Ltd Major Business
Table 97. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product and Solutions
Table 98. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Glenmark Pharmaceuticals Ltd Recent Developments and Future Plans
Table 100. Global Oral Anti-diabetes Drugs Revenue (USD Million) by Players (2018-2023)
Table 101. Global Oral Anti-diabetes Drugs Revenue Share by Players (2018-2023)
Table 102. Breakdown of Oral Anti-diabetes Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Oral Anti-diabetes Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Oral Anti-diabetes Drugs Players
Table 105. Oral Anti-diabetes Drugs Market: Company Product Type Footprint
Table 106. Oral Anti-diabetes Drugs Market: Company Product Application Footprint
Table 107. Oral Anti-diabetes Drugs New Market Entrants and Barriers to Market Entry
Table 108. Oral Anti-diabetes Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Oral Anti-diabetes Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Oral Anti-diabetes Drugs Consumption Value Share by Type (2018-2023)
Table 111. Global Oral Anti-diabetes Drugs Consumption Value Forecast by Type (2024-2029)
Table 112. Global Oral Anti-diabetes Drugs Consumption Value by Application (2018-2023)
Table 113. Global Oral Anti-diabetes Drugs Consumption Value Forecast by Application (2024-2029)
Table 114. North America Oral Anti-diabetes Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Oral Anti-diabetes Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Oral Anti-diabetes Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Oral Anti-diabetes Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Oral Anti-diabetes Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Oral Anti-diabetes Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Oral Anti-diabetes Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Oral Anti-diabetes Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Oral Anti-diabetes Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Oral Anti-diabetes Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Oral Anti-diabetes Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Oral Anti-diabetes Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Oral Anti-diabetes Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Oral Anti-diabetes Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Oral Anti-diabetes Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Oral Anti-diabetes Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Oral Anti-diabetes Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Oral Anti-diabetes Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Oral Anti-diabetes Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Oral Anti-diabetes Drugs Raw Material
Table 145. Key Suppliers of Oral Anti-diabetes Drugs Raw Materials
List of Figures
Figure 1. Oral Anti-diabetes Drugs Picture
Figure 2. Global Oral Anti-diabetes Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral Anti-diabetes Drugs Consumption Value Market Share by Type in 2022
Figure 4. Liquid
Figure 5. Capsule
Figure 6. Tablet
Figure 7. Global Oral Anti-diabetes Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Oral Anti-diabetes Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Oral Anti-diabetes Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Oral Anti-diabetes Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Oral Anti-diabetes Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Oral Anti-diabetes Drugs Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Oral Anti-diabetes Drugs Consumption Value Market Share by Region in 2022
Figure 17. North America Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Oral Anti-diabetes Drugs Revenue Share by Players in 2022
Figure 23. Oral Anti-diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Oral Anti-diabetes Drugs Market Share in 2022
Figure 25. Global Top 6 Players Oral Anti-diabetes Drugs Market Share in 2022
Figure 26. Global Oral Anti-diabetes Drugs Consumption Value Share by Type (2018-2023)
Figure 27. Global Oral Anti-diabetes Drugs Market Share Forecast by Type (2024-2029)
Figure 28. Global Oral Anti-diabetes Drugs Consumption Value Share by Application (2018-2023)
Figure 29. Global Oral Anti-diabetes Drugs Market Share Forecast by Application (2024-2029)
Figure 30. North America Oral Anti-diabetes Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Oral Anti-diabetes Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Oral Anti-diabetes Drugs Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Oral Anti-diabetes Drugs Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Oral Anti-diabetes Drugs Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Oral Anti-diabetes Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. France Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Oral Anti-diabetes Drugs Consumption Value Market Share by Region (2018-2029)
Figure 47. China Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. India Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Oral Anti-diabetes Drugs Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Oral Anti-diabetes Drugs Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Oral Anti-diabetes Drugs Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Oral Anti-diabetes Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Oral Anti-diabetes Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Oral Anti-diabetes Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Oral Anti-diabetes Drugs Market Drivers
Figure 65. Oral Anti-diabetes Drugs Market Restraints
Figure 66. Oral Anti-diabetes Drugs Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Oral Anti-diabetes Drugs in 2022
Figure 69. Manufacturing Process Analysis of Oral Anti-diabetes Drugs
Figure 70. Oral Anti-diabetes Drugs Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi Eli Lilly AstraZeneca plc Astellas Pharma Inc Johnson & Johnson (Janssen Pharmaceuticals) Boehringer Ingelheim Merck Takeda Bristol Myers Squibb Novartis Pfizer Abbott Biocon Sunpharma Novo Nordisk Piramal Healthcare Bayer Healthcare Dr. Reddy’s Laboratories Ltd Glenmark Pharmaceuticals Ltd
Related Reports
24 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
